Innovative Therapies for Eye Diseases
SELAGINE, Inc. develops novel topical biologic immunotherapies for treatment of immunological and inflammatory ocular surface diseases such as Sjögren’s syndrome and ocular Graft-versus-Host Disease.
SELAGINE, Inc. develops novel topical biologic immunotherapies for treatment of immunological and inflammatory ocular surface diseases such as Sjögren’s syndrome and ocular Graft-versus-Host Disease.